StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Monday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Shares of NAVB opened at $0.00 on Monday. The company has a market capitalization of $20,016.00, a P/E ratio of 0.00 and a beta of 0.75. The firm has a 50 day moving average of $0.03 and a 200 day moving average of $0.04. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.15.
Navidea Biopharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- Retail Stocks Investing, Explained
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- What is the Nikkei 225 index?
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Insider Trading – What You Need to Know
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.